Dr. Jeff Karp is a co-founder of Alivio Therapeutics and is a Professor at Brigham and Women’s Hospital, Harvard Medical School. He has published more than 100 peer-reviewed papers, has given over 200 national and international invited lectures and has 65 issued or pending patents. The Boston Business Journal recognized him as a Champion in Healthcare Innovation and he was recognized by MIT’s Technology Review Magazine’s TR35. His work has been selected as one of Popular Mechanic’s “Top 20 New Biotech Breakthroughs that Will Change Medicine.” In 2015 he received a Breakthrough Award from the Kenneth Rainin Foundation and was a commencement speaker at the University of Toronto. He was recently named to the Top 40 Under 40 business leaders by the Boston Business Journal.